Regulatory News In Brief: Dakota Lab shutters, FDA warns on web links and supplement GMPs, melanotan caution in U.K.
This article was originally published in The Tan Sheet
Executive Summary
Dakota Labs shutters under decree; Herbal Papaya web links render products drugs; FDA flags firms for GMPs; U.K. watchdog cites ketone marketer; MHRA cautions against melanotan use; and Aidapak recalls products from hospitals.
You may also be interested in...
Sun Product Research Heats Up; U.K. Agency Warns About Unapproved OTC
As pharmaceutical firms work on injectable products that in the future could compete with sunscreens and suntan oils and lotions, health authorities in the U.K. warn that an unapproved drug marketed as "injectable tan" is being sold over the counter there
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.